B-cell immune checkpoint TIM-1: a potential target for tumour immunotherapy

被引：2
|
作者：
Tian, Xinyu [1 ,2 ]
Zheng, Xiangyun [1 ,2 ]
Tian, Dong [1 ,2 ]
机构：
[1] Sichuan Univ, West China Hosp, Dept Thorac Surg, 37 Guoxue Alley, Chengdu 610041, Peoples R China
[2] Sichuan Univ, West China Hosp, Inst Thorac Oncol, Lung Transplant Res Lab, 37 Guoxue Alley, Chengdu 610041, Peoples R China
来源：
SIGNAL TRANSDUCTION AND TARGETED THERAPY | 2023年 / 8卷 / 01期
关键词：
D O I：
10.1038/s41392-023-01643-w
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
[No abstract available]
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Grouper TIM-1 promotes nodavirus infection by inhibiting immune and inflammation response
    Lin, Long
    Zhao, Yin
    Ma, Yiting
    Xi, Kaitao
    Jin, Yunyong
    Huang, Xiaohong
    Huang, Youhua
    Zhang, Ya
    Qin, Qiwei
    FISH & SHELLFISH IMMUNOLOGY, 2024, 153
  • [42] The immune checkpoint TIGIT is upregulated on T cells during bacterial infection and is a potential target for immunotherapy
    Mcculloch, Timothy R.
    Rossi, Gustavo R.
    Miranda-Hernandez, Socorro
    Valencia-Hernandez, Ana Maria
    Alim, Louisa
    Belle, Clemence J.
    Krause, Andrew
    Zacchi, Lucia F.
    Lam, Pui Yeng
    Nakamura, Kyohei
    Kupz, Andreas
    Wells, Timothy J.
    Souza-Fonseca-Guimaraes, Fernando
    IMMUNOLOGY AND CELL BIOLOGY, 2024, 102 (08): : 721 - 733
  • [43] TIM-1 Signaling Is Required for Maintenance and Induction of Regulatory B Cells
    Yeung, M. Y.
    Ding, Q.
    Brooks, C. R.
    Xiao, S.
    Workman, C. J.
    Vignali, D. A. A.
    Ueno, T.
    Padera, R. F.
    Kuchroo, V. K.
    Najafian, N.
    Rothstein, D. M.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2015, 15 (04) : 942 - 953
  • [44] TIM-1 Promotes Hepatitis C Virus Cell Attachment and Infection
    Wang, Jing
    Qiao, Luhua
    Hou, Zhouhua
    Luo, Guangxiang
    JOURNAL OF VIROLOGY, 2017, 91 (02)
  • [45] The B-cell compartment as the selective target for the treatment of immune thrombocytopenias
    Zaja, F
    Vianelli, N
    Sperotto, A
    De Vita, S
    Iacona, I
    Zaccaria, A
    Masolini, P
    Tomadini, V
    Tani, M
    Molinari, AL
    Baccarani, M
    Fanin, R
    HAEMATOLOGICA, 2003, 88 (05) : 538 - 546
  • [46] Immune Checkpoint Protein Vista as a Novel Target for Cancer Immunotherapy
    Wang, Li
    Noelle, Randolph
    LeMercier, Isabelle
    Lines, Janet
    Sergent, Petra
    JOURNAL OF IMMUNOTHERAPY, 2012, 35 (09) : 781 - 781
  • [47] PD-1–PD-L1 immune-checkpoint blockade in B-cell lymphomas
    Aaron Goodman
    Sandip P. Patel
    Razelle Kurzrock
    Nature Reviews Clinical Oncology, 2017, 14 : 203 - 220
  • [48] Immunotherapy for B-cell lymphoma
    Nagler, Arnon
    Shimoni, Avichai
    LEUKEMIA & LYMPHOMA, 2010, 51 (01) : 7 - 9
  • [49] Immunotherapy in the B-cell lymphomas
    Gribben, JG
    CYTOTHERAPY, 2002, 4 (05) : 439 - 440
  • [50] CLEC-1 suppress dendritic cell antigen presentation and is a novel myeloid immune checkpoint target for cancer immunotherapy
    Drouin, Marion
    Saenz, Javier
    Evrard, Berangere
    Gauttier, Vanessa
    Teppaz, Geraldine
    Lopez-Robles, Maria-Dolores
    Louvet, Cedric
    Poirier, Nicolas
    Chiffoleau, Elise
    CANCER RESEARCH, 2020, 80 (16)
12345